Featured Research

from universities, journals, and other organizations

Good samaritan from Germany donates bone marrow cells to save American's life

Date:
September 9, 2013
Source:
Loyola University Health System
Summary:
A young man from Germany donated bone marrow cells to save the life of a complete stranger. The cells helped to cure Murphy of a blood disorder called MDS that otherwise would have been fatal. They recently met for the first time.

Two years ago, a young man from Germany named Manuel Auge donated some of his bone marrow to save the life of a complete stranger, Thomas Murphy of Burr Ridge.

The bone marrow transplant cured Murphy of a blood disorder called MDS that otherwise would have been fatal.

On Sunday, Sept. 8, Auge and Murphy met for the first time, during the 25th Annual Bone Marrow Transplant Celebration of Survivorship at Loyola’s Cardinal Bernardin Cancer Center. More than 400 patients, family members and friends attended.

Murphy, who lives in Burr Ridge, had a blood disorder called myelodysplastic syndrome. MDS causes immature blood cells to accumulate in the bone marrow, leading to a shortage of mature blood cells. Mature blood cells that are made also can be defective.

To kill the defective cells, Murphy received high-dose chemotherapy and whole-body radiation. He then received healthy new blood-forming stem cells that came from Auge’s bone marrow.

“You saved my life,” Murphy told Auge moments after they met. “You’re a star.”

Auge, a physics student in Tullmenau, Germany, said, “If you could save the life of a person, I think you should do it. It gives you a good feeling.”

Murphy’s physician, Dr. Patrick Stiff, said, “Mr. Auge is as much a hero as a fireman who pulls a person out of a burning building. Because he donated his cells, Mr. Murphy is alive and healthy today.”


Story Source:

The above story is based on materials provided by Loyola University Health System. Note: Materials may be edited for content and length.


Cite This Page:

Loyola University Health System. "Good samaritan from Germany donates bone marrow cells to save American's life." ScienceDaily. ScienceDaily, 9 September 2013. <www.sciencedaily.com/releases/2013/09/130909152842.htm>.
Loyola University Health System. (2013, September 9). Good samaritan from Germany donates bone marrow cells to save American's life. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/09/130909152842.htm
Loyola University Health System. "Good samaritan from Germany donates bone marrow cells to save American's life." ScienceDaily. www.sciencedaily.com/releases/2013/09/130909152842.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins